Home > Healthcare > Medical Devices > Medical Supplies > Amniocentesis Needle Market

Amniocentesis Needle Market Size

  • Report ID: GMI8186
  • Published Date: Feb 2024
  • Report Format: PDF

Amniocentesis Needle Market Size

Amniocentesis Needle Market size was valued at around USD 177 million in 2023 and is anticipated to register a CAGR of 4.9% between 2024 and 2032. Amniocentesis needle refers to a specialized medical instrument used in the amniocentesis procedure, which is a diagnostic test performed during pregnancy. The needle is designed for the purpose of extracting a small amount of amniotic fluid from the amniotic sac surrounding a developing fetus.

 

This robust market growth can be attributed to various factors, including ongoing technological advancements in amniocentesis needles, rising prevalence of chronic diseases among expectant mothers, growing awareness and education regarding amniocentesis, the continual growth of healthcare expenditure, and the increasing preference for ultrasound needles, which accounted for USD 272.5 million in 2022, among other contributing factors.

 

Furthermore, anticipated market expansion is attributed to multiple factors, including the, raising maternal age and increasing rates of prenatal screening. For instance, in 2022, according to BMC Pregnancy and Childbirth in pregnancies of advanced maternal age (AMA), invasive diagnostic testing was performed in 87.22% cases.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Amniocentesis needle market size was USD 177 million in 2023 and is expected to reach over USD 273.1 million by 2032 owing to ongoing technological advancements in amniocentesis needles and rising prevalence of chronic diseases among expectant mothers worldwide.

Amniocentesis needle industry from the 100-150 mm segment reached USD 94.6 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their striking balance between being long enough to reach the amniotic sac safely and short enough to minimize the risk of complications.

North America amniocentesis needle industry recorded USD 71.8 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of a sophisticated healthcare system with access to advanced medical technologies in the region.

Becton Dickinson and Company, Biopsybell Srl, Cook Medical, CooperSurgical, Inc., Integra LifeSciences Corporation, Laboratoire CCD, Medline Industries, Inc., Medtronic plc, RI.MOS. Srl, and Rocket Medical plc., are some of the major amniocentesis needle companies worldwide.

Amniocentesis Needle Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 215
  • Countries covered: 22
  • Pages: 133
 Download Free Sample